On January 3, 2017, the Board of Directors of Corvus Pharmaceuticals, Inc. approved, by means of a written consent in lieu of special meeting and upon the recommendation of the nominating and corporate governance committee of the Board, an action to increase the size of the Board from six directors to seven directors and elected Ian T. Clark as a director to fill the vacancy created by the increase to the size of the Board and as a member of the compensation committee and nominating and corporate governance committee of the Board. Mr. Clark will serve as a Class III director with a term of office commencing on January 3, 2017 and expiring at the Company's 2018 annual meeting of stockholders or until his successor is duly elected and qualified, or his earlier death, resignation or removal.